Cubist Systematic Strategies, LLC Annexon, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $36,471 - $70,680	-9,050 Reduced 52.79%	8,094 $58,000
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $27,944 - $79,376	17,144 New	17,144 $77,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $6.37 $19,687 - $59,718	-9,375 Reduced 10.57%	79,323 $279,000
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $280,238 - $558,977	74,930 Added 544.23%	88,698 $341,000
Q4 2022 Feb 14, 2023	SELL	$4.56 - $6.61 $32,540 - $47,168	-7,136 Reduced 34.14%	13,768 $71,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $130,682 - $251,456	-61,935 Reduced 74.77%	20,904 $79,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $138,064 - $603,841	50,573 Added 156.74%	82,839 $226,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $298,671 - $571,868	25,994 Added 414.45%	32,266 $371,000
Q3 2021 Nov 15, 2021	BUY	$16.35 - $23.4 $102,547 - $146,764	6,272 New	6,272 $117,000

158

101M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $332M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.